Cochrane Abstracts
Recombinant human activated protein C for severe sepsis in neonates
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Recombinant Human Activated Protein C for Severe Sepsis in Neonates." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/438613/all/Recombinant_human_activated_protein_C_for_severe_sepsis_in_neonates.
Recombinant human activated protein C for severe sepsis in neonates. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438613/all/Recombinant_human_activated_protein_C_for_severe_sepsis_in_neonates. Accessed March 16, 2025.
Recombinant human activated protein C for severe sepsis in neonates. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438613/all/Recombinant_human_activated_protein_C_for_severe_sepsis_in_neonates
Recombinant Human Activated Protein C for Severe Sepsis in Neonates [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 March 16]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/438613/all/Recombinant_human_activated_protein_C_for_severe_sepsis_in_neonates.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Recombinant human activated protein C for severe sepsis in neonates
ID - 438613
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/438613/all/Recombinant_human_activated_protein_C_for_severe_sepsis_in_neonates
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
